Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
39.66
-0.40 (-1.00%)
Jun 29, 2026, 10:39 AM EDT - Market open
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.9 billion as of June 29, 2026. Its market cap has increased by 366.53% in one year.
Market Cap
1.90B
Enterprise Value
1.45B
1-Year Change
366.53%
Ranking
Category
Stock Price
$39.66
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.90B, an increase of 215.40%. That is a compound annual growth rate of 74.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.90B | 31.17% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.98B |
| Nuvation Bio | 1.97B |
| AtaiBeckley | 1.95B |
| GH Research | 1.94B |
| Lakefront Biotherapeutics NV | 1.93B |
| Sionna Therapeutics | 1.90B |
| Iovance Biotherapeutics | 1.90B |
| Tyra Biosciences | 1.90B |